/Companies

Yseop

5 known investors

Find your way into Yseop

Each arrow is one introduction. Sign up to fill in the first one.

264 people can intro you to Emmanuel

Ask Scott Davis to introduce you to Emmanuel Walckenaer

You →Scott · together at Sierrawireless →Emmanuel

Sign up to find every way you can get introduced to Yseop

  • Your email: who you already know at Yseop, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Yseop team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Yseop provides an AI-powered platform that automates medical writing and regulatory reporting tasks for life sciences teams, accelerating document submission timelines within the CTD pyramid framework. The platform uses neuro-symbolic AI to transform complex documentation workflows and ensure compliance in pharmaceutical regulatory processes.

Founders & leadership

EWEmmanuel Walckenaer
Emmanuel WalckenaerCEOEmmanuel Walckenaer is CEO of Yseop, which provides an AI-powered platform for automating medical writing and regulatory reporting in the pharmaceutical industry. He has prior experience in healthcare, IoT, artificial intelligence, and wireless sectors, with expertise in sales, business strategy, and mergers and acquisitions.

Investors · 5

Also in the syndicate · 3

Eli LillyNextStage AMNovartis (dRx Capital)

Funding

SEC filings, press & company announcements
  • Undisclosed amountstrategic investment roundDec 2023

    Eli Lilly, NextStage AM, Novartis (dRx Capital), Wille Finance

    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Yseop do?
Yseop provides an AI-powered platform that automates medical writing and regulatory reporting tasks for life sciences teams, accelerating document submission timelines within the CTD pyramid framework. The platform uses neuro-symbolic AI to transform complex documentation workflows and ensure compliance in pharmaceutical regulatory processes.
Who are Yseop's investors?
Yseop's investors include Claret Capital Partners, Wille Finance.